Home/Filings/4/0001179110-17-010234
4//SEC Filing

INVIVO THERAPEUTICS HOLDINGS CORP. 4

Accession 0001179110-17-010234

CIK 0001292519operating

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 8:03 PM ET

Size

5.5 KB

Accession

0001179110-17-010234

Insider Transaction Report

Form 4
Period: 2017-07-05
Toselli Richard M.
Chief Medical Officer
Transactions
  • Award

    Stock option(right to buy)

    2017-07-05+325,000325,000 total
    Exercise: $2.55Exp: 2027-07-05Common Stock (325,000 underlying)
Footnotes (1)
  • [F1]This option vests as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001292519

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 8:03 PM ET
Size
5.5 KB